PRESS RELEASE published on 01/02/2024 at 14:00, 8 months 16 days ago Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European Market Catheter Precision, Inc. announced the allowance of two new patents (No. 6288592 and No. 015023977-0001) in Great Britain and the European Market for its LockeT product line, further solidifying the company's IP position. These patents demonstrate the company's commitment to the uniqueness of the closure product design, strengthening its global presence in the electrophysiology products market. Catheter Precision Inc. LockeT Patents Electrophysiology Products Medical Device Company Great Britain And European Market
PRESS RELEASE published on 12/22/2023 at 14:00, 8 months 27 days ago Catheter Precision, Inc. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-Q
PRESS RELEASE published on 12/18/2023 at 14:00, 9 months ago CATHETER PRECISION, INC. Reports Filing of 10-Q and Second Quarter Results of Operations
PRESS RELEASE published on 12/05/2023 at 14:00, 9 months 13 days ago Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Emerging Growth Conference on December 6, 2023 Catheter Precision, Inc. (NYSE American:VTAK) to present its innovative non-invasive 3D mapping system, VIVO, at the Emerging Growth Conference on December 6, 2023. The event offers an opportunity for real-time interaction with the CEO Catheter Precision Inc. Medical Device Company VIVO Emerging Growth Conference 3D Mapping System
PRESS RELEASE published on 11/20/2023 at 14:00, 9 months 28 days ago Catheter Precision's (VTAK) First Successful VIVO(TM) Cases Completed in Croatia Sets Stage for Expansion into South-Eastern Europe
PRESS RELEASE published on 10/12/2023 at 14:00, 11 months 6 days ago Catheter Precision’s VIVO is Now Eligible for National Reimbursement in the UK
PRESS RELEASE published on 10/10/2023 at 14:00, 11 months 8 days ago Catheter Precision Showcasing its Innovative 3D Mapping System
PRESS RELEASE published on 09/07/2023 at 14:00, 1 year ago Catheter Precision, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
PRESS RELEASE published on 08/31/2023 at 14:00, 1 year ago Catheter Precision Secures New Distribution Partner for Southeast Asia
PRESS RELEASE published on 08/25/2023 at 14:00, 1 year ago Catheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q
Published on 09/18/2024 at 23:10, 4 hours 1 minute ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 4 hours 11 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 56 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 6 hours 11 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 10 hours 41 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 7 hours 59 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 8 hours 25 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 8 hours 39 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 8 hours 57 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 9 hours 49 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 8 hours 25 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 8 hours 25 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 9 hours 31 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.